Cynthia D Simpson, QBHP | |
2707 Browns Ln, Jonesboro, AR 72401-7213 | |
(870) 972-4939 | |
(870) 972-4911 |
Full Name | Cynthia D Simpson |
---|---|
Gender | Female |
Speciality | Case Manager/care Coordinator |
Location | 2707 Browns Ln, Jonesboro, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104121383 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | L50608 (Arkansas) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cynthia D Simpson, QBHP 2707 Browns Ln, Jonesboro, AR 72401-7213 Ph: (870) 972-4939 | Cynthia D Simpson, QBHP 2707 Browns Ln, Jonesboro, AR 72401-7213 Ph: (870) 972-4939 |
News Archive
Epilepsy and depression are common co-morbidities. Concern for the potential of certain antidepressants to induce seizures has led to under-treating depression and anxiety disorders in epilepsy patients. Research presented today at the 66th American Epilepsy Society meeting suggests that antidepressants in normal dosage may have a positive impact on both mood and seizure frequency.
CNP Assurances, the leading personal insurer in France, with operations in the rest of Europe and in South America, has announced its premium income and net profit figures for the first quarter of 2010.
The Council for Citizens Against Government Waste today called upon Congress to reject any attempts to alter the nation's healthcare system using parliamentary gimmicks and urged members to vote against the bill.
Australia is a leader in digital mental health technologies; this week experts will gather at the University of Sydney to forge a path for unbiased, safe and quality mental health apps.
Cellectis, the French genome engineering specialist, and Harvard Apparatus, a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, have announced today that they have signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, the full line of electroporation-based instruments acquired by Cellectis from CytoPulse in September of 2010.
› Verified 9 days ago